Tilray Brands (TLRY) Invested Capital (2017 - 2026)
Tilray Brands' (TLRY) quarterly Invested Capital came in at $124.8 million in Q2 2026, up 172.13% YoY from $45.9 million in Q2 2025, and up 178.0% on a QoQ basis from $44.9 million in Q1 2026.
Tilray Brands (TLRY) Invested Capital (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Invested Capital data on file, last reported at $124.8 million in Q2 2026.
- Quarterly Invested Capital rose 172.13% year-over-year to $124.8 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $260.4 million (up 42.03% YoY) and the FY2026 annual result came in at $124.8 million, up 172.13% from the prior year.
- Invested Capital rose to $124.8 million in Q2 2026, from $44.9 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $251.6 million in Q3 2023 to a low of $44.9 million in Q3 2024.
- A 5-year average of $88.7 million and a median of $57.2 million in 2023 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2023 — Invested Capital surged 292.51% — and 2024, when it plunged 82.17%.
- Tracing TLRY's Invested Capital over 5 years: stood at $181.5 million in 2022, then plunged by 68.41% to $57.3 million in 2023, then decreased by 18.87% to $46.5 million in 2024, then slipped by 2.79% to $45.2 million in 2025, then surged by 175.92% to $124.8 million in 2026.
- The last three Invested Capital figures came in at $124.8 million (Q2 2026), $44.9 million (Q1 2026), and $45.2 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 124.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 124.79 Mn |
| Feb 28, 2026 | 44.89 Mn |
| Nov 30, 2025 | 45.23 Mn |
| Aug 31, 2025 | 45.55 Mn |
| May 31, 2025 | 45.86 Mn |
| Feb 28, 2025 | 46.14 Mn |
| Nov 30, 2024 | 46.52 Mn |
| Aug 31, 2024 | 44.85 Mn |
| May 31, 2024 | 45.04 Mn |
| Feb 29, 2024 | 57.04 Mn |
| Nov 30, 2023 | 57.35 Mn |
| Aug 31, 2023 | 251.59 Mn |
| May 31, 2023 | 174.38 Mn |
| Feb 28, 2023 | 184.08 Mn |
| Nov 30, 2022 | 181.51 Mn |
| Aug 31, 2022 | 64.10 Mn |
| May 31, 2022 | 67.82 Mn |
| Feb 28, 2022 | 70.18 Mn |
| Nov 30, 2021 | 62.34 Mn |
| Aug 31, 2021 | 61.49 Mn |